[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Endocrinology](https://durgical.com/en/endocrinology/) › [Hypothalamus and pituitary](https://durgical.com/en/endocrinology/areas/pituitary/) › Acromegaly: IGF-1, the glucose load and the face that changed

# Acromegaly: IGF-1, the glucose load and the face that changed

- Diagnostic test

Acromegaly changes a face so slowly that family and doctors miss it for years. A blood test called IGF-1 catches it, and a sugar drink confirms it.

Updated Nov 15, 2026

**See it in 3D:** [Pituitary gland](https://durgical.com/en/anatomy/pituitary-gland/) · [Sella turcica](https://durgical.com/en/anatomy/sella-turcica/)

## Key points

- Screen with IGF-1, confirm with GH not suppressed by an oral [glucose](https://durgical.com/en/biochemistry/molecules/glucose/) load.
- Random GH is useless for diagnosis.
- Most are macroadenomas at diagnosis; surgery is first line.
- Mortality comes from heart disease, diabetes and sleep apnoea: screen them.
- GH receptor antagonist → follow IGF-1, not GH.

On this page

- The basics Key points
- What it is
- How to think about it
- How to read the result
- How it is done
- Reading IGF-1 and the glucose-suppressed GH together
- Common pitfalls
- Common traps
- Elsewhere in DurgiPedia

- Treatment Next step / Initial management

- Study Test yourself

- Connections Connections

## What it is

Acromegaly is the result of [growth hormone](https://durgical.com/en/pharmacology/classes/growth-hormone/) (GH) excess after the growth plates have closed; before closure it causes gigantism. Almost all cases come from a GH-secreting [pituitary adenoma](https://durgical.com/en/conditions/pituitary-adenoma/), most of them macroadenomas by the time of diagnosis; ectopic GHRH secretion is rare. GH acts largely through insulin-like growth factor 1 (IGF-1), made in the [liver](https://durgical.com/en/anatomy/liver/). The workup screens with IGF-1, confirms with an oral glucose tolerance test that fails to suppress GH, images the pituitary, and looks for the complications that shorten life: diabetes, hypertension, cardiomyopathy, sleep apnoea and [colon polyps](https://durgical.com/en/conditions/colorectal-polyps-and-hereditary-polyposis-syndromes/).

## How to think about it

GH is a pulsing signal and IGF-1 is its running average. A single GH value catches a pulse or a trough and tells you little, so you screen with the average. Then you apply the feedback rule for suspected excess: try to suppress it. Glucose silences normal somatotroph cells; an autonomous adenoma ignores the glucose.

## How to read the result

- IGF-1 above the age- and sex-adjusted range is the screening test; it reflects GH over the previous weeks.
- Confirmation: GH that does not fall below the assay cut-off (commonly 1 µg/L, or 0.4 µg/L with sensitive assays) during an oral glucose tolerance test.
- IGF-1 is falsely low in liver disease, malnutrition, poorly controlled diabetes, [hypothyroidism](https://durgical.com/en/conditions/hypothyroidism/) and with oral oestrogen; it is normally high in [puberty](https://durgical.com/en/physiology/puberty/) and pregnancy.
- A random GH is not diagnostic: healthy pulses and stress can make it high.
- Clues: larger hands and feet (rings and shoes no longer fit), coarse face, jaw growth with gaps between [teeth](https://durgical.com/en/embryology/teeth/), sweating, [carpal tunnel syndrome](https://durgical.com/en/conditions/carpal-tunnel-syndrome/), headaches and joint pain.
- Diagnosis is typically delayed by several years; comparing old photographs is a useful bedside test.
- Acromegaly can be part of an inherited syndrome (MEN1, Carney complex, AIP mutation), especially in young patients.

## How it is done

- Suspect it from the features, or from an incidental [pituitary mass](https://durgical.com/en/endocrinology/the-sellar-mass-three-questions/).
- Measure IGF-1 and read it against the range for age and sex.
- IGF-1 high or equivocal: oral glucose tolerance test with timed GH samples.
- GH not suppressed: pituitary MRI with contrast.
- Test the rest of the pituitary (prolactin, [cortisol](https://durgical.com/en/biochemistry/molecules/cortisol/), thyroid, gonadal axis) and visual fields if the tumour reaches the chiasm.
- Screen complications: glucose and [HbA1c](https://durgical.com/en/biochemistry/topics/glycated-haemoglobin/), [blood pressure](https://durgical.com/en/physiology/systolic-diastolic-mean-and-pulse-pressure/), echocardiogram, sleep study, colonoscopy and [thyroid examination](https://durgical.com/en/clinical-exam/thyroid-examination/).

## Reading IGF-1 and the glucose-suppressed GH together

| IGF-1 | GH after glucose | Meaning |
| --- | --- | --- |
| High | Not suppressed | Acromegaly: image the pituitary |
| Normal | Suppressed | Acromegaly excluded |
| High | Suppressed | Puberty, pregnancy, assay problem; repeat or reconsider |
| Normal or low | Not suppressed | Uncontrolled diabetes, liver or kidney failure, malnutrition, anorexia, oral oestrogen |

## Common pitfalls

- The glucose test is hard to read in uncontrolled diabetes, kidney or liver failure and anorexia: GH can fail to suppress without acromegaly.
- During treatment with a GH receptor antagonist, GH rises and the GH assay is unreliable: monitor IGF-1 only.
- «Pseudoacromegaly» (coarse features from insulin resistance or drugs) has a normal IGF-1.

## Next step / Initial management

- IGF-1 first; glucose-suppressed GH to confirm; pituitary MRI only after biochemical confirmation.
- Transsphenoidal surgery is the first-line treatment for most patients; cure is judged on IGF-1 and GH about three months after surgery.
- Not cured or not operable: [somatostatin analogues](https://durgical.com/en/pharmacology/classes/somatostatin-analogues/), a GH receptor antagonist, sometimes [cabergoline](https://durgical.com/en/pharmacology/cabergoline/), and [radiotherapy](https://durgical.com/en/nursing/radiation-therapy-skin-care-fatigue-and-safety-with-implants-and-radioactive-sou/).
- Refer every suspected case to endocrinology and an experienced pituitary surgeon.

## Common traps

- **A random GH confirms or excludes acromegaly**: GH is pulsatile, so a single random value can do neither.
- **IGF-1 can be read against the adult range in anyone**: in a teenager or pregnant woman the adult range does not apply.
- **An adenoma on MRI confirms acromegaly**: going straight to MRI without biochemical confirmation finds non-functioning incidental adenomas.
- **GH tracks control on a GH receptor antagonist**: it does not, so GH is not monitored in a patient on this drug.
- **Treating the tumour is the whole job**: the heart, sleep apnoea and colon screening decide survival and must not be forgotten.

## Test yourself

Think of the answer, then tap the question to see it.

## Why is IGF-1, rather than a random GH, the screening test for acromegaly?

GH is secreted in pulses and varies minute to minute; IGF-1 integrates GH action over weeks and is stable.

## What is the principle behind the oral glucose tolerance test in acromegaly?

Suspected excess is tested by suppression: glucose normally switches GH off, but an autonomous adenoma keeps secreting.

## A man with poorly controlled diabetes has a normal IGF-1 but GH fails to suppress after glucose. Does he have acromegaly?

Probably not: uncontrolled diabetes can blunt GH suppression. A normal IGF-1 argues against acromegaly.

## Which value should be used to monitor a patient treated with a GH receptor antagonist, and why?

IGF-1. The drug blocks GH action, so GH itself rises and is measured unreliably.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/endocrinology/acromegaly-igf-1-the-glucose-load-and-the-face-that-changed/)

## Elsewhere in DurgiPedia

- [Growth hormone and IGF-1](https://durgical.com/en/physiology/growth-hormone-and-igf-1/)
- [Somatotroph PitNET: gigantism and acromegaly](https://durgical.com/en/general-pathology/somatotroph-pitnet-gigantism-and-acromegaly/)
- [Pituitary neuroendocrine tumours (PitNETs): overview](https://durgical.com/en/general-pathology/pituitary-neuroendocrine-tumours-overview/)

## Connections

## See it in 3D 2

The structures of Durgical's 3D anatomy where it is found.

- [Pituitary gland](https://durgical.com/en/anatomy/pituitary-gland/)
- [Sella turcica](https://durgical.com/en/anatomy/sella-turcica/)

## Related 5

- [The sellar mass: three questions](https://durgical.com/en/endocrinology/the-sellar-mass-three-questions/)
- [Stimulate if too little, suppress if too much: dynamic tests](https://durgical.com/en/endocrinology/stimulate-if-too-little-suppress-if-too-much-dynamic-tests/)
- [Why hormone tests mislead: timing, binding proteins and assay interference](https://durgical.com/en/endocrinology/why-hormone-tests-mislead-timing-binding-proteins-and-assay-interference/)
- [After pituitary surgery: water, cortisol and the three phases](https://durgical.com/en/endocrinology/after-pituitary-surgery-water-cortisol-and-the-three-phases/)
- [When to think of an inherited endocrine syndrome: MEN1, MEN2 and their relatives](https://durgical.com/en/endocrinology/when-to-think-of-an-inherited-endocrine-syndrome-men1-men2-and-their-relatives/)

## Related conditions 6

- [Acromegaly and gigantism](https://durgical.com/en/conditions/acromegaly-and-gigantism/)
- [Pituitary adenoma](https://durgical.com/en/conditions/pituitary-adenoma/)
- [Obstructive sleep apnoea](https://durgical.com/en/conditions/obstructive-sleep-apnoea/)
- [Carpal tunnel syndrome](https://durgical.com/en/conditions/carpal-tunnel-syndrome/)
- [Colorectal cancer](https://durgical.com/en/conditions/colorectal-cancer/)
- [Multiple endocrine neoplasia (MEN 1, 2A, 2B)](https://durgical.com/en/conditions/multiple-endocrine-neoplasia/)

## In Pharmacology 7

- [Somatostatin analogues](https://durgical.com/en/pharmacology/classes/somatostatin-analogues/)
- [Octreotide](https://durgical.com/en/pharmacology/octreotide/)
- [Lanreotide](https://durgical.com/en/pharmacology/lanreotide/)
- [Pasireotide](https://durgical.com/en/pharmacology/pasireotide/)
- [Growth hormone receptor antagonists](https://durgical.com/en/pharmacology/classes/growth-hormone-receptor-antagonists/)
- [Pegvisomant](https://durgical.com/en/pharmacology/pegvisomant/)
- [Cabergoline](https://durgical.com/en/pharmacology/cabergoline/)

[← All of endocrinology](https://durgical.com/en/endocrinology/)

Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.

Sources: [Acromegaly](https://www.ncbi.nlm.nih.gov/books/NBK431086/) (StatPearls (NCBI Bookshelf), 2023); [Pituitary Adenoma](https://www.ncbi.nlm.nih.gov/books/NBK554451/) (StatPearls (NCBI Bookshelf), 2025); [Imaging of the Pituitary Gland](https://www.ncbi.nlm.nih.gov/books/NBK555989/) (StatPearls (NCBI Bookshelf), 2023).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/endocrinology/acromegaly-igf-1-the-glucose-load-and-the-face-that-changed/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/endocrinology/acromegaly-igf-1-the-glucose-load-and-the-face-that-changed/
